01553nas a2200217   4500000000100000008004100001260003000042653003900072653004400111653001400155653002000169653001800189100001100207700001300218700001800231700001300249245012600262300001200388520091700400020001801317       2023                            d  bSpringer Nature Singapore10aNeglected tropical diseases (NTDs)10aProduct development partnerships (PDPs)10aPortfolio10aOpen innovation10aGlobal health1 aKita K1 aYamada H1 aHirabayashi F1 aCroft SL00aDevelopment of Portfolios and Pipelines of Drugs for the Treatment, Prevention and Control of Neglected Tropical Diseases  a283-2963 a<p>Over the past quarter of a century, the extent and impact of neglected tropical diseases (NTDs) on populations worldwide have been determined, and both treatment and control measures have been developed. Product development partnerships (PDPs) have been established to bring forward new tools for these efforts. A huge movement, including international organizations, academia, pharmaceutical and biotech sectors, committed to advancing the treatment, control and elimination of NTDs has grown over this period. The leading role of PDPs has not only been to develop and implement new tools but also acted as an effective catalyst to encourage and enable pharma and academia to engage in these diseases, to establish portfolios to enable choice and to connect to other innovative public–private partnerships that can deliver new and established treatments and control measures to neglected populations.</p>
  a9789819961627